Recombinant Human ESRRA Protein，His

ESRRA (Estrogen Related Receptor Alpha) is a member of the nuclear receptor superfamily that plays a crucial role in various physiological processes, including metabolism, cell differentiation, and tissue homeostasis. Its involvement in the regulation of gene expression makes it a potential target for therapeutic interventions in diverse conditions such as obesity, diabetes, and cancer. Research over the past few decades has indicated that ESRRA is not only implicated in metabolic pathways but also plays a pivotal role in the body's response to estrogen, linking it to reproductive health and certain hormone-dependent cancers. The functional characteristics of ESRRA are influenced by its ability to form heterodimers with other nuclear receptors and interact with cofactors, which modulates its transcriptional activity. The recombinant expression of ESRRA protein allows for in-depth studies of its structure and function, enabling researchers to investigate the molecular mechanisms underlying its regulatory actions. Additionally, understanding ESRRA's role in various signaling pathways may provide insights into its potential as a biomarker for disease prognosis and treatment strategies. The stringent regulation of ESRRA activity highlights its importance in maintaining cellular homeostasis, making it a focal point for ongoing research in molecular biology and pharmacology. By harnessing recombinant technology to produce ESRRA, scientists aim to elucidate its functional properties, paving the way for future therapeutic developments that target this nuclear receptor and its related pathways.